Remove Clinical Research Remove Genetics Remove Life Science Remove Pharma Companies
article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

article thumbnail

Deep Dive: Oncology 2022

pharmaphorum

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Scotland Saleko adds that Scotland, as a devolved nation, has an innovative NHS system that has propelled it to become a key site for translational medical research. From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC).

Drugs 75
article thumbnail

The Unprecedented Growth of Cell and Gene Therapy (2021)

Cloudbyz

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. Moreover, 12% of industrial clinical pipeline products and at least 16% of preclinical pipeline products consist of CGT.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. Recro – CDMO company Recro announced David Enloe as its new president and CEO.

article thumbnail

Glen de Vries, Medidata Co-Founder, Dies in Plane Crash Weeks After Space Flight

XTalks

deVries co-founded Medidata in 1999 as a provider of technological software solutions to advance clinical research. Dassault Systèmes acquired the company in 2019 and de Vries was serving as the Life Sciences & Healthcare vice-chair for the new parent company.

article thumbnail

Top 10 Clinical Trial Trends for 2024

XTalks

The field of clinical research will witness significant advancements in 2024. Read on to learn about the top 10 clinical trial trends for 2024, and be sure to explore and join upcoming webinars about clinical trials at Xtalks. Blockchain can enhance data security and compliance by creating immutable data records.